The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
Many of the manifestations of hyperthyroidism are secondary to increased adrenergic activity. In recent years the beta adrenergic blocking drugs, as represented by d,1-propranolol, have become the agents of choice for ameliorating the adrenergic signs and symptoms of hyperthyroidism. Propranolol improves the tachycardia, tremor, restlessness, anxiety, and myopathy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006145:Guanethidine / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology*; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine